Sign in

CIK 0001528115

  • Non-accelerated filer
  • Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275414423
Phone
+1 650-822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
Open-market buys, last 90 days
$99,829
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Love Douglas +$100K PRESIDENT AND CEO 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-06-11 Choi Jung Director Grant or award · Stock Option (Right to Buy) +65,000 65,000
2025-12-01 Choi Jung Director Purchase +33,000 $4.19 $138K 33,000
2025-06-05 Choi Jung Director Grant or award · Stock Option (Right to Buy) +55,000 55,000
2024-06-05 Choi Jung Director Grant or award · Stock Option (Right to Buy) +44,000 44,000
2023-06-08 Choi Jung Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2022-06-09 Choi Jung Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2021-06-02 Choi Jung Director Grant or award · Stock Option (Right to Buy) +10,000 10,000

Page 1 of 1 · 7 trades